BallerAlert on MSN14h
Say Goodbye to Shots! FDA Approves First Self-Administered Flu Vaccine Nasal Spray
The Food and Drug Administration (FDA) has greenlit the first-ever self-administered flu vaccine, FluMist. The agency made the announcement on Friday, explaining that FluMist is a convenient nasal ...
FDA approves first flu vaccine that can be self-administered at home
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
CNET19h
What to Know About Novavax, the 'Other' COVID Vaccine
Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.
EuropaWire23h
Pfizer and BioNTech’s Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive EU Opinion, Awaiting Approval
Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 vaccine has received a positive recommendation from the European ...
FDA approves at-home flu vaccine
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
FDA approves first nasal spray flu vaccine for use at home
FluMist is the only nasal flu vaccine, but it is not new. The FDA approved it in 2003 for people 5 to 49 years old before ...
At-home flu vaccines get FDA approval
For the first time, adults will be able to administer their own flu vaccines after the FDA approved a nasal spray to be administered without a health care provider ...
FDA approves nasal flu vaccine for at-home use
The Food and Drug Administration has approved the first nasal flu vaccine. People can order the vaccine from pharmacies and administer it at home. NBC News' Dr. Vin Gupta breaks down the significance ...
FDA approves first self-administered flu vaccine
The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...
KPBS1d
No needles required: The FDA approves an at-home flu vaccine
The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the ...
BioNTech SE: Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted ...